A Breakthrough in Pain Management: Inside the Promise of Journavx
Risk & Insurance - Apr 03, 2025
Enlyte’s Nikki Wilson offers a fresh take on a promising alternative to opioids, a first-of-its-kind FDA-approved non-addictive medication for pain. The post A Breakthrough in Pain Management: Inside the Promise of Journavx appeared first on Risk & Insurance. ...
Recommended Articles
Posted: Apr 04, 2025
The latest people news in the industry today. The post Marsh Appoints Amy Barnes as Global Head of E...
Posted: Apr 04, 2025
Sensors collecting hyper-localized data on dozens of environmental factors are helping to build a be...
Posted: Apr 03, 2025
Insurance leaders embrace AI transformation to revolutionize operations, but implementation challeng...